Skip to main content

Table 3 Comparison of the non-HDL-C differences according to neurological scores

From: Association between serum non-high-density lipoprotein cholesterol and cognitive impairment in patients with acute ischemic stroke

 

Higher than normal non-HDL-C levels (208 cases)

Critical high non-HDL-C levels (183 cases)

Very high non-HDL-C levels (81 cases)

P

NIHSS

4.0 ± 1.3

3.6 ± 1.1a

4.8 ± 1.8

0.043

NPI

3.9 ± 1.2

4.1 ± 1.2

4.9 ± 1.5ab

0.021

BI

84.1 ± 14.6

84.8 ± 14.4

82.9 ± 16.1

0.217

MMSE

24.9 ± 4.6

24.6 ± 5.1

22.6 ± 6.0ab

<0.001

MoCA

20.5 ± 5.0

20.6 ± 5.9

18.3 ± 4.3ab

0.002

ADL

26.3 ± 8.2

26.5 ± 8.4

29.2 ± 10.3

0.450

HAMD

4.8 ± 1.3

4.7 ± 1.0

4.2 ± 2.7

0.634

  1. NIHSS NIH stroke score, MMSE mini-mental state examination, MoCA Montreal Cognitive Assessment, NPI, Neuropsychiatric Inventory, ADL Activity of Daily Living Scalem, HADM-21 Hamilton depression rating scale 21-item
  2. aANOVA and LSD post hoc test: P < 0.05 vs. the higher than normal non-HDL-C group
  3. bANOVA and LSD post hoc test: P < 0.05 vs. the critical high non-HDL-C group
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us